VIATRIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Viatris Inc. and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Viatris Inc. for allegedly providing misleading information regarding the FDA's warning letter related to its Indore, India facility, which impacted the company's operations [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Viatris securities between August 8, 2024, and February 26, 2025 [1]. - Investors have until June 3, 2025, to apply to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations - The complaint claims that Viatris misrepresented the significance of the FDA's warning letter, downplaying it as a "minor headwind" for the company [2].